rheumatoid arthritis glp 1 GLP-1 Drugs Reduce Symptoms Treating Rheumatoid Arthritis with GLP-1

An early publication in the Annals of the New York Academy of Sciences documenting the original discovery of telomere shortening as a primary mechanism of cellular senescence and its relevance to human aging biology provides the foundational framework for understanding why telomerase-activating compounds attract longevity research attention

Regular hormone panels and metabolic checks (IGF-1, glucose, and lipid levels) are recommended every 36 months for long-term balance

Dosing should be individualized and titrated according to clinical response, typically starting at 30 mg three times daily and increasing in 30 mg increments every 23 days to a target range of 60120 mg per dose every 36 hours

10.1074/jbc.M114.574335 268 SuX.WellenK

Antibiotics in early life alter the murine colonic microbiome and adiposity